• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV770T
Medical Device Problem Code Infusion or Flow Problem (2964)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 02/02/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a prosa shunt system (part # fv770t) was implanted during a procedure performed on an unknown date.According to the complainant, the shunt system was believed to be operating in overdrainage.The patient underwent a revision procedure performed on (b)(6) 2023.The complaint device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 83 years.Height: 178 centimeters (cm).Weight: 85 kilograms (kg).Gender: male.
 
Additional Manufacturer Narrative
Investigation: visual inspection: the following was detected during the visual inspection: deformation of the outer housing of the prosa.The measurement of the plane.Parallelism could confirm that with a value of -0,068 mm - outside tolerance (0 ± 0.02 mm).Bloody residues on the catheter.Bloody deposits in the control reservoir.Tissue residues on the inlet spout of the control reservoir.Permeability test: a permeability test has indicated that the control reservoir has a blockage and that the prosa and progav are permeable.During the permeability test bloody liquid was flushing out.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.The results show that the valves operate within the accepted tolerance in both positions.Adjustment test: the prosa and progav was tested and are adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances in both valves.Internal inspection: after dismantling of the valves, deposits were found in both valves.Results: based on our investigation results, we can determine a blockage in the shunt system.The determined deposits can be named as the cause for the blockage.Proteins in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA SYS W/ADJ.DP.UNIT A.CONTROL RES.
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key16507773
Report Number3004721439-2023-00041
Device Sequence Number17737854
Product Code JXG
UDI-Device Identifier04041906135553
UDI-Public4041906135553
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K120559
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/19/2022
Device Model NumberFV770T
Device Catalogue NumberFV770T
Device Lot Number20033126
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/06/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/06/2023
Initial Report FDA Received Date03/08/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/23/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age83 YR
Patient SexMale
Patient Weight85 KG
-
-